Ngā hua rapu - Manuel Magallanes

  • E whakaatu ana i te 1 - 4 hua o te 4
Whakamahine hua
  1. 1
    A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

    A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer mā José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes, Dae Ho Lee, Jie Wang, Vinod Ganju, Luis Manuel Martínez-Barrera, Helen Barraclough, Maximiliano Van Kooten, Mauro Orlando

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 mā Christian Marth, R. Tarnawski, Alexandra Tyulyandina, Sandro Pignata, Lucy Gilbert, Diego Kaen, María Jesús Rubio, Sophia Frentzas, Mario Beiner, Manuel Magallanes-Maciel, Laura Farrelly, Chel Hun Choi, Regina Berger, Christine Lee, Christof Vulsteke, Kosei Hasegawa, Elena Ioana Braicu, Xiaohua Wu, Jodi A. McKenzie, John J. Lee, Vicky Makker

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

    Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) mā Óscar Arrieta, Andrés F. Cardona, Claudio Martín, Luís Más, Luis Corrales, Guillermo F. Bramuglia, O. Castillo, Matthew Meyerson, Eduardo Amieva-Rivera, Alma D. Campos-Parra, Hernán Carranza, Juan Carlos Gómez de la Torre, Yanina Powazniak, Fernando Aldaco-Sarvide, Carlos Vargas, Mariana Trigo, Manuel Magallanes-Maciel, Jorge Otero, Roberto Sánchez-Reyes, Mauricio Cuello

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

    Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors mā Brian M. Slomovitz, David Cibula, Weiguo Lv, Fırat Ortaç, Sakari Hietanen, Floor Backes, Akira Kikuchi, Domenica Lorusso, Anna Dańska-Bidzińska, Vanessa Samouëlian, Maria-Pilar Barretina-Ginesta, Christof Vulsteke, Chyong‐Huey Lai, Bhavana Pothuri, Liang Yu, Manuel Magallanes-Maciel, Amnon Amit, Valentina Guarneri, Flora Zagouri, Maria C. Bell, Julia Welz, Gemma Eminowicz, Martin Hruda, Lyndsay Willmott, Jasmine Lichfield, Wei Wang, Robert Orlowski, Gursel Aktan, Laurence Gladieff, Toon Van Gorp

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: